Related references
Note: Only part of the references are listed.Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery plus /- neoadjuvant chemotherapy
He-Yuan Hsieh et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging
Tao Wang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Jingxuan Fu et al.
RADIATION ONCOLOGY (2019)
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience
Salvatore Del Prete et al.
ONCOLOGY LETTERS (2019)
Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study
Caixia Sun et al.
EBIOMEDICINE (2019)
Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma
Uanderson Resende et al.
ONCOLOGY (2018)
Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer
Lobna Ouldamer et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Shabierjiang Jiapaer et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Cancer of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy
Tae-Wook Kong et al.
GYNECOLOGIC ONCOLOGY (2016)
Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer
Jing Li et al.
CANCER MEDICINE (2016)
Neoadjuvant chemotherapy in cervical cancer: an update
Mariateresa Lapresa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
N. Katsumata et al.
BRITISH JOURNAL OF CANCER (2013)
Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study
Mingzhu Yin et al.
PLOS ONE (2013)
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer
Jong-Sup Park et al.
GYNECOLOGIC ONCOLOGY (2011)
Pathologic Response Rate After Concomitant Neo-Adjuvant Radiotherapy and Chemotherapy for Adenocarcinoma of the Uterine Cervix A Retrospective Multicentric Study
Olivier Poujade et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: A randomized study
Huijun Chen et al.
GYNECOLOGIC ONCOLOGY (2008)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance Imaging
NA Mayr et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospects
DT Rein et al.
ANTI-CANCER DRUGS (2001)
Share Paper
